Header Logo

Connection

John Pezzuto to Drug Discovery

This is a "connection" page, showing publications John Pezzuto has written about Drug Discovery.
Connection Strength

0.722
  1. Mirza B, Kondratyuk TP, Park EJ, Burns BE, Marler LE, Pezzuto JM. Preliminary evaluation for cancer chemopreventive and cytotoxic potential of naturally growing ethnobotanically selected plants of Pakistan. Pharm Biol. 2013 Mar; 51(3):316-28.
    View in: PubMed
    Score: 0.379
  2. Chen L, Conda-Sheridan M, Reddy PV, Morrell A, Park EJ, Kondratyuk TP, Pezzuto JM, van Breemen RB, Cushman M. Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventive agents. J Med Chem. 2012 Jun 28; 55(12):5965-81.
    View in: PubMed
    Score: 0.092
  3. Kondratyuk TP, Park EJ, Yu R, Van Breemen RB, Asolkar RN, Murphy BT, Fenical W, Pezzuto JM. Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agents. Mar Drugs. 2012 Feb; 10(2):451-464.
    View in: PubMed
    Score: 0.090
  4. Lewandowski C, Pezzuto JM. Pharmaceutical Biology: a retrospective. Pharm Biol. 2012 Jan; 50(1):1-5.
    View in: PubMed
    Score: 0.088
  5. Mi Q, Pezzuto JM, Farnsworth NR, Wani MC, Kinghorn AD, Swanson SM. Use of the in vivo hollow fiber assay in natural products anticancer drug discovery. J Nat Prod. 2009 Mar 27; 72(3):573-80.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.